BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 38672714)

  • 1. Role of Tumor-Associated Macrophages in Cervical Cancer: Integrating Classical Perspectives with Recent Technological Advances.
    Choi Y; Lee D; Kim NY; Seo I; Park NJ; Chong GO
    Life (Basel); 2024 Mar; 14(4):. PubMed ID: 38672714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.
    Wu K; Lin K; Li X; Yuan X; Xu P; Ni P; Xu D
    Front Immunol; 2020; 11():1731. PubMed ID: 32849616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage diversity in human cancers: New insight provided by single-cell resolution and spatial context.
    Rakina M; Larionova I; Kzhyshkowska J
    Heliyon; 2024 Apr; 10(7):e28332. PubMed ID: 38571605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
    Gao J; Liang Y; Wang L
    Front Immunol; 2022; 13():888713. PubMed ID: 35844605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between tumor-associated macrophage infiltration and progression in cervical carcinoma.
    Guo F; Kong W; Zhao G; Cheng Z; Ai L; Lv J; Feng Y; Ma X
    Biosci Rep; 2021 May; 41(5):. PubMed ID: 33928349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of NFATc1/c-myc/PKM2/IL-10 axis in activating cervical cancer tumor-associated M2 macrophage polarization to promote cervical cancer progression.
    Tan J; Yang L; Zhao H; Ai Y; Ren L; Zhang F; Dong W; Shi R; Sun D; Feng Y
    Exp Cell Res; 2022 Apr; 413(2):113052. PubMed ID: 35122827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M1
    Garrido-Martin EM; Mellows TWP; Clarke J; Ganesan AP; Wood O; Cazaly A; Seumois G; Chee SJ; Alzetani A; King EV; Hedrick CC; Thomas G; Friedmann PS; Ottensmeier CH; Vijayanand P; Sanchez-Elsner T
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.
    Dallavalasa S; Beeraka NM; Basavaraju CG; Tulimilli SV; Sadhu SP; Rajesh K; Aliev G; Madhunapantula SV
    Curr Med Chem; 2021; 28(39):8203-8236. PubMed ID: 34303328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tumor-associated macrophages in the tumor microenvironment.
    Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
    Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis.
    Yin M; Shen J; Yu S; Fei J; Zhu X; Zhao J; Zhai L; Sadhukhan A; Zhou J
    Onco Targets Ther; 2019; 12():8687-8699. PubMed ID: 31695427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
    Hwang I; Kim JW; Ylaya K; Chung EJ; Kitano H; Perry C; Hanaoka J; Fukuoka J; Chung JY; Hewitt SM
    J Transl Med; 2020 Nov; 18(1):443. PubMed ID: 33228719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 Endometrial Cancer is Associated With a High Density of Tumor-Associated Macrophages in the Stromal Compartment.
    Kelly MG; Francisco AM; Cimic A; Wofford A; Fitzgerald NC; Yu J; Taylor RN
    Reprod Sci; 2015 Aug; 22(8):948-53. PubMed ID: 25701837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy.
    Schweer D; McAtee A; Neupane K; Richards C; Ueland F; Kolesar J
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophages as a potential therapeutic target in thyroid cancers.
    Zhu L; Li XJ; Gangadaran P; Jing X; Ahn BC
    Cancer Immunol Immunother; 2023 Dec; 72(12):3895-3917. PubMed ID: 37796300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development.
    Zhang C; Wei S; Dai S; Li X; Wang H; Zhang H; Sun G; Shan B; Zhao L
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
    Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slit2 Inhibits Breast Cancer Metastasis by Activating M1-Like Phagocytic and Antifibrotic Macrophages.
    Ahirwar DK; Charan M; Mishra S; Verma AK; Shilo K; Ramaswamy B; Ganju RK
    Cancer Res; 2021 Oct; 81(20):5255-5267. PubMed ID: 34400395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC
    Li X; Zhang Q; Chen G; Luo D
    Front Immunol; 2021; 12():694801. PubMed ID: 34295336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.